Tapering chronic opioid therapy in neuropathic facial pain: An interdisciplinary approach

Authors

  • Brijesh P. Chandwani, BDS, FOP
  • Ronald J. Kulich, PhD
  • Lainie Andrew, PhD
  • Steven Scrivani, DDS, DMedSc

DOI:

https://doi.org/10.5055/jom.2008.0022

Keywords:

neuropathic face pain, opioid therapy, behavioral therapy, psychological treatment, opioid taper, appliance therapy

Abstract

This case report presents a patient with chronic orofacial pain who was considered to be an appropriate candidate for chronic opioid therapy, a treatment uncommonly considered at most facial pain centers. Her opioid treatment proved ineffectual, and conservative approaches were addressed. She was successfully tapered off the use of a long-acting opioid within a relatively short time, using an interdisciplinary approach involving an aggressive biobehavioral approach.

Author Biographies

Brijesh P. Chandwani, BDS, FOP

Assistant Professor, Craniofacial Pain and Headache Center, Tufts University, Boston, Massachusetts.

Ronald J. Kulich, PhD

Associate Professor, Craniofacial Pain and Headache Center, Tufts University, Boston, Massachusetts; Lecturer, Harvard Medical School, Department of Anesthesia, Pain Center, Massachusetts General Hospital, Boston, Massachusetts.

Lainie Andrew, PhD

Associate Professor, Craniofacial Pain and Headache Center, Tufts University, Boston, Massachusetts.

Steven Scrivani, DDS, DMedSc

Professor, Craniofacial Pain and Headache Center, Tufts University, Boston, Massachusetts.

References

Stewart WF, Ricci JA, Chee E, et al.: Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003; 290(18): 2443-2454.

Watson CP: Management issues of neuropathic trigeminal pain from a medical perspective. J Orofac Pain. 2004; 18(4): 366-373.

Merskey H, Bogduk N (ed.): Classification of Chronic Pain. Description of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: IASP Press, 1994.

Henry JL: Future basic science directions into mechanisms of neuropathic pain. J Orofac Pain. 2004; 18(4): 306-310.

Furlan AD, Sandoval JA, Mailis-Gagnon A, et al.: Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006; 174(11): 1589-1594.

Savage SR: Opioid therapy of chronic pain: Assessment of consequences. Acta Anaesthesiol Scand. 1999; 43(9): 909-917.

Gamsa A: The role of psychological factors in chronic pain. Pain. 1994; 57(1): 5-15.

Linton SJ, Gotesam KG: Relations between pain, anxiety, mood and muscle tension in chronic pain patients. Psychother Psychosom. l985; 43: 95-98.

Muse M: Stress-related, post-traumatic chronic pain syndrome: Criteria for diagnosis, and preliminary report on prevalence. Pain. l985; 23: 295-300.

Lee MHM: Physical therapy and rehabilitation medicine. In Bonica JJ (ed.): The Management of Pain. Philadelphia: Lea and Febiger, 1990; 1769-1788.

Bruera E, Kim HN: Cancer pain. JAMA. 2003; 290: 2476-2479.

Deshpande A, Furlan A, Mailis-Gagnon A, et al.: Opioids for chronic low-back pain. Cochrane Database Sys Rev. 2007; 3: CD004959.

Gimbel JS. Richards P, Portenoy RK: Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology. 2003; 60(6): 927-934.

Eisenberg E, McNicol E, Carr DB: Opioids for neuropathic pain. Cochrane Database Sys Rev. 2006; 3: CD006146.

Xu XJ, Colpaert F, Wiesenfeld-Hallin Z: Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance. Trends Pharmacol Sci. 2003; 24(12): 634-639.

Dworkin SF, LeResche L: Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandibular Disord. 1992; 6(4): 301-355. [Review] [152 refs].

Akbik H, Butler SF, Budman SH, et al.: Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006; 32(3): 287-293.

Belgrade MJ, Schamber CD, Lindgren BR.: The DIRE score: Predicting outcomes of opioid prescribing for chronic pain. Pain. 2006; 7(9): 671-681.

Ekberg E, Vallon, N: Occlusal appliance therapy in patients with temporomandibular disorders: A double blind controlled study in a short-term perspective. Acta Odontol Scand. 1998; 56(2): 122-128.

Kavan MG, Guck TP, Barone EJ: A practical guide to crisis management. Am Family Physician. 2006; 74(7): 1159-1164.

Ware JE, Kosinski M: SF-36 Physical & Mental Health Summary Scales: A Manual for Users of Version 1. 2nd ed. Lincoln, RI: Quality Metric Incorporated, 2001.

Chu L, Clark DJ, Angst M: Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain. 2006; 7: 43-48.

Angst M, Clark JD: Opioid induced hyperalgesia. Anesthesiology. 2006; 104: 570-587.

Charlton EJ (ed.): Core Curriculum for Professional Education in Pain. Seattle: IASP Press, 2005; Chapter 39: 198.

Gilron I, Watson CP, Cahill CM, et al.: Neuropathic pain: A practical guide for the clinician. Can Med Assoc J. 2006; 175(3): 265-275.

Dworkin RH, Backonja M, Rowbotham MC, et al.: Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60(11): 1524-1534.

Rome JD, Townsend CO, Bruce BK, et al.: Chronic non cancer pain rehabilitation with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Mayo Clinic Proc. 2004; 79(6): 759-768.

McCracken LM, Eccleston C.: Coping or acceptance: What to do about chronic pain? Pain. 2003; 105(1/2): 197-204.

Downloads

Published

01/30/2018

How to Cite

Chandwani, BDS, FOP, B. P., R. J. Kulich, PhD, L. Andrew, PhD, and S. Scrivani, DDS, DMedSc. “Tapering Chronic Opioid Therapy in Neuropathic Facial Pain: An Interdisciplinary Approach”. Journal of Opioid Management, vol. 4, no. 3, Jan. 2018, pp. 167-71, doi:10.5055/jom.2008.0022.

Issue

Section

Case Studies